开发氨酸核酸酸化酶向小分子的前景和挑战
Yangyang Chen1, Yang Li1, Jing Gao1
1Department of Neurology, Laboratory of Neuro-system and Multimorbidity and State Key Laboratory of Biotherapy and Cancer Center and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
European journal of medicinal chemistry
|May 3, 2024
概括
纯核酸酸酶 (PNP) 对于细胞功能和免疫反应至关重要. 针对PNP的抑制剂在治疗T细胞癌症和免疫性疾病方面表现有前途.
科学领域:
- 生物化学 生化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 纯氨酸核酸酶 (PNP) 是一种细胞酶,是纯氨酸代谢的核心.
- PNP与细胞功能,免疫反应以及淋巴瘤和白血病等癌症的发展有关.
- 它的T细胞向特征使得PNP成为特定癌症和免疫疾病的重要治疗点.
研究的目的:
- 审查最近开发小分子PNP抑制剂的进展.
- 讨论PNP的结构,生物功能和疾病相关性.
- 探索设计新型PNP治疗剂的潜在策略.
主要方法:
- 小分子PNP抑制剂的文献综述.
- 对PNP结构与活动关系的分析.
- 对现有PNP抑制剂的临床试验数据的评估.
主要成果:
- 已经开发了几种小分子PNP抑制剂,Peldesine,Forodesine和Ulodesine进入临床试验.
- 这些抑制剂在治疗T细胞白血病和痛风方面具有潜力.
- 目前正在进行的研究重点是增强抑制剂的效力,选择性和药理动力学特性.
结论:
- PNP抑制剂代表了T细胞恶性瘤和某些免疫性疾病的有前途的治疗策略.
- 对PNP抑制剂设计的持续研究对于开发更有效的治疗方法至关重要.
- 优化功效,选择性和药理动力学是PNP向治疗的关键未来方向.
相关概念视频
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K


